U.S. market Closed. Opens in 11 hours 33 minutes

GSK | GSK plc Stock Fundamentals

(Stock Exchange: NYSE)
Analyzing fundamentals for GSK we got that it has average fundamentals where Valuation is considered to be undervalued, Profitability is moderate, Growth is bad and Health is weak.

Valuation (79%)

Company Industry
P/E Ratio (TTM) 32.56 47.52
PEG Ratio (TTM) 0.33 5.18
P/S Ratio (TTM) 2.09 9.13
P/B Ratio (TTM) 9.14 25.99
P/FCF Ratio (TTM) 13.91 -48.06
Price to 5YR AVG Earnings Ratio 33.12 61.95
Price to 5YR AVG FCF Ratio 16.55 94.45

Profitability (60%)

Company Industry
ROA (TTM) 6.95% 8.52%
ROE (TTM) 29.50% 36.12%
Net Profit Margin (TTM) 12.83% 17.02%
ROIC 5YR AVG 20.90% 20.76%

Growth (42%)

4QTR AVG 3YR AVG 5YR AVG
EPS 31.70% -6.07% -5.83%
Revenue 2.71% 3.53% -0.01%
Net Income 31.26% 9.42% 8.12%
Cash Flow 7.27% -1.77% -5.29%

Health (49%)

Company Industry
Current Ratio (TTM) 0.82 1.10
Quick Ratio (TTM) 0.54 0.87
D/E Ratio (TTM) 1.18 2.86
Interest Coverage (TTM) 9.37 13.85
Piotroski F-Score 7 6
Altman Z-Score 2.16 4.97
LTL to 5YR AVG FCF 2.70 4.10
Shares Outstanding Growth 5YR AVG 21.75% 1.15%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙